These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36527335)

  • 1. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
    Dottermusch M; Schüller U; Hagel C; Saeger W
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.
    Dottermusch M; Ryba A; Ricklefs FL; Flitsch J; Schmid S; Glatzel M; Saeger W; Neumann JE; Schüller U
    Acta Neuropathol; 2024 Jan; 147(1):16. PubMed ID: 38228887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pathological Features of Pit1/SF1 Multilineage Pituitary Neuroendocrine Tumor.
    Wang X; Tang H; Bie Z; Wang Y; Yuan R; Zhang Z; Xiong Z; Yang Z; Bi Z; Wang B; Liu P
    Neurosurgery; 2024 Jan; ():. PubMed ID: 38289085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative epigenomics indicate a common origin of ectopic and intrasellar corticotroph pituitary neuroendocrine tumors/adenomas: a case report.
    Barrantes-Freer A; Braune M; Sandner B; Dottermusch M; Lindner D
    Virchows Arch; 2024 Feb; ():. PubMed ID: 38347267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs.
    Inoshita N; Yoshimoto T; Takazawa Y; Fukuhara N; Okada M; Nishioka H; Yamada S
    Brain Tumor Pathol; 2023 Jul; 40(3):158-162. PubMed ID: 37072666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives.
    Wan XY; Chen J; Wang JW; Liu YC; Shu K; Lei T
    Curr Med Sci; 2022 Dec; 42(6):1111-1118. PubMed ID: 36544040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
    Xie J; Wu ZB
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020.
    Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Raverot G; Roncaroli F; Villa C
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription Factor Immunohistochemistry in the Classification of Pituitary Neuroendocrine Tumor/Adenoma: Proposal in a Limited-Resource Setting.
    Sood R; Chatterjee D; Dutta P; Radotra BD
    Arch Pathol Lab Med; 2024 Feb; 148(2):178-189. PubMed ID: 37074863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors.
    Turchini J; Sioson L; Clarkson A; Sheen A; Gill AJ
    Endocr Pathol; 2020 Jun; 31(2):150-155. PubMed ID: 32193825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
    Asa SL; Mete O; Riddle ND; Perry A
    Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis.
    Tebani A; Jotanovic J; Hekmati N; Sivertsson Å; Gudjonsson O; Edén Engström B; Wikström J; Uhlèn M; Casar-Borota O; Pontén F
    Acta Neuropathol Commun; 2021 Nov; 9(1):181. PubMed ID: 34758873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [WHO Histological Classification of Pituitary Tumors].
    Nishioka H
    No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience.
    Mihajlović M; Pekić S; Doknić M; Stojanović M; Rašić D; Miljić D; Petakov M; Manojlović Gačić E
    Int J Surg Pathol; 2024 May; 32(3):470-477. PubMed ID: 37438981
    [No Abstract]   [Full Text] [Related]  

  • 20. Newer Concepts in the Classification of Pituitary Adenomas.
    Sathyakumar R; Chacko G
    Neurol India; 2020; 68(Supplement):S7-S12. PubMed ID: 32611886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.